February 12, 2020

Deal Drivers EMEA FY2019

In partnership with Mergermarket

The new Deal Drivers report reveals that 2019 M&A activity in EMEA slowed from the peaks experienced in past years. The drop is unsurprising, given geopolitical and economic headwinds across the region: trade disputes, Brexit uncertainty and slowing economies all affected M&A activity in 2019. However, activity did not fall apace with the severe drop experienced in 2H18. Notably:

  • The pharma, medical & biotech sector in Europe had another extraordinary year, with a 15% rise on 2018;
  • Europe’s industrials & chemicals sector outperformed the other sectors by winning 20% of all deal volume across Europe;
  • Bucking global trends, European consumer sector M&A was up 26% from 2018.
  • Total M&A deal value in MENA (ex Israel) was €107.2bn, equal to the cumulative total of the prior four years;
  • The Saudi Aramco-SABIC deal was the largest in the global chemical space, at €62.5bn.

Read the full report to learn more about M&A activity and trends in the region, including heat charts, adviser league tables and sector analysis.

You may also like:

As the Tide Turns, What’s Next? H2 2022 Market Outlook

If 2021 was a high water mark for M&A, then 2022 is seeing the ebbing of the tide. In our latest report in association with PitchBook, Datasite assesses the new outlook for dealmakers.

The New State of M&A: Africa, Middle East & Turkey

Most Africa, Middle East & Turkey M&A practitioners believe new technologies should enable greater analytical capability, and security, in the due diligence process over the next five years. How else can technology help them and in what areas?

Deal Drivers: APAC Q1 2022

M&A activity across the APAC region as a whole slipped in Q1, which was to be expected after a record-setting 2021. It’s a trend that can be observed across geographic markets an is best understood as a reversion to the mean rather than a cause for concern at this stage. Learn more from our latest Deal Drivers report.